purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Contraceptive Drugs and Devices Market Size Analysis from 2022 to 2027

1.5.1 Global Contraceptive Drugs and Devices Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Contraceptive Drugs and Devices Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Contraceptive Drugs and Devices Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Contraceptive Drugs and Devices Industry Impact

Chapter 2 Global Contraceptive Drugs and Devices Competition by Types, Applications, and Top Regions and Countries

2.1 Global Contraceptive Drugs and Devices (Volume and Value) by Type

2.1.1 Global Contraceptive Drugs and Devices Consumption and Market Share by Type (2016-2021)

2.1.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Type (2016-2021)

2.2 Global Contraceptive Drugs and Devices (Volume and Value) by Application

2.2.1 Global Contraceptive Drugs and Devices Consumption and Market Share by Application (2016-2021)

2.2.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Application (2016-2021)

2.3 Global Contraceptive Drugs and Devices (Volume and Value) by Regions

2.3.1 Global Contraceptive Drugs and Devices Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Contraceptive Drugs and Devices Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Contraceptive Drugs and Devices Consumption by Regions (2016-2021)

4.2 North America Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

4.10 South America Contraceptive Drugs and Devices Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Contraceptive Drugs and Devices Market Analysis

5.1 North America Contraceptive Drugs and Devices Consumption and Value Analysis

5.1.1 North America Contraceptive Drugs and Devices Market Under COVID-19

5.2 North America Contraceptive Drugs and Devices Consumption Volume by Types

5.3 North America Contraceptive Drugs and Devices Consumption Structure by Application

5.4 North America Contraceptive Drugs and Devices Consumption by Top Countries

5.4.1 United States Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

5.4.2 Canada Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

5.4.3 Mexico Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 6 East Asia Contraceptive Drugs and Devices Market Analysis

6.1 East Asia Contraceptive Drugs and Devices Consumption and Value Analysis

6.1.1 East Asia Contraceptive Drugs and Devices Market Under COVID-19

6.2 East Asia Contraceptive Drugs and Devices Consumption Volume by Types

6.3 East Asia Contraceptive Drugs and Devices Consumption Structure by Application

6.4 East Asia Contraceptive Drugs and Devices Consumption by Top Countries

6.4.1 China Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

6.4.2 Japan Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

6.4.3 South Korea Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 7 Europe Contraceptive Drugs and Devices Market Analysis

7.1 Europe Contraceptive Drugs and Devices Consumption and Value Analysis

7.1.1 Europe Contraceptive Drugs and Devices Market Under COVID-19

7.2 Europe Contraceptive Drugs and Devices Consumption Volume by Types

7.3 Europe Contraceptive Drugs and Devices Consumption Structure by Application

7.4 Europe Contraceptive Drugs and Devices Consumption by Top Countries

7.4.1 Germany Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.2 UK Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.3 France Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.4 Italy Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.5 Russia Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.6 Spain Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.7 Netherlands Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.8 Switzerland Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

7.4.9 Poland Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 8 South Asia Contraceptive Drugs and Devices Market Analysis

8.1 South Asia Contraceptive Drugs and Devices Consumption and Value Analysis

8.1.1 South Asia Contraceptive Drugs and Devices Market Under COVID-19

8.2 South Asia Contraceptive Drugs and Devices Consumption Volume by Types

8.3 South Asia Contraceptive Drugs and Devices Consumption Structure by Application

8.4 South Asia Contraceptive Drugs and Devices Consumption by Top Countries

8.4.1 India Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

8.4.2 Pakistan Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Contraceptive Drugs and Devices Market Analysis

9.1 Southeast Asia Contraceptive Drugs and Devices Consumption and Value Analysis

9.1.1 Southeast Asia Contraceptive Drugs and Devices Market Under COVID-19

9.2 Southeast Asia Contraceptive Drugs and Devices Consumption Volume by Types

9.3 Southeast Asia Contraceptive Drugs and Devices Consumption Structure by Application

9.4 Southeast Asia Contraceptive Drugs and Devices Consumption by Top Countries

9.4.1 Indonesia Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

9.4.2 Thailand Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

9.4.3 Singapore Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

9.4.4 Malaysia Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

9.4.5 Philippines Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

9.4.6 Vietnam Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

9.4.7 Myanmar Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 10 Middle East Contraceptive Drugs and Devices Market Analysis

10.1 Middle East Contraceptive Drugs and Devices Consumption and Value Analysis

10.1.1 Middle East Contraceptive Drugs and Devices Market Under COVID-19

10.2 Middle East Contraceptive Drugs and Devices Consumption Volume by Types

10.3 Middle East Contraceptive Drugs and Devices Consumption Structure by Application

10.4 Middle East Contraceptive Drugs and Devices Consumption by Top Countries

10.4.1 Turkey Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.3 Iran Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.5 Israel Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.6 Iraq Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.7 Qatar Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.8 Kuwait Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

10.4.9 Oman Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 11 Africa Contraceptive Drugs and Devices Market Analysis

11.1 Africa Contraceptive Drugs and Devices Consumption and Value Analysis

11.1.1 Africa Contraceptive Drugs and Devices Market Under COVID-19

11.2 Africa Contraceptive Drugs and Devices Consumption Volume by Types

11.3 Africa Contraceptive Drugs and Devices Consumption Structure by Application

11.4 Africa Contraceptive Drugs and Devices Consumption by Top Countries

11.4.1 Nigeria Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

11.4.2 South Africa Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

11.4.3 Egypt Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

11.4.4 Algeria Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

11.4.5 Morocco Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 12 Oceania Contraceptive Drugs and Devices Market Analysis

12.1 Oceania Contraceptive Drugs and Devices Consumption and Value Analysis

12.2 Oceania Contraceptive Drugs and Devices Consumption Volume by Types

12.3 Oceania Contraceptive Drugs and Devices Consumption Structure by Application

12.4 Oceania Contraceptive Drugs and Devices Consumption by Top Countries

12.4.1 Australia Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

12.4.2 New Zealand Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 13 South America Contraceptive Drugs and Devices Market Analysis

13.1 South America Contraceptive Drugs and Devices Consumption and Value Analysis

13.1.1 South America Contraceptive Drugs and Devices Market Under COVID-19

13.2 South America Contraceptive Drugs and Devices Consumption Volume by Types

13.3 South America Contraceptive Drugs and Devices Consumption Structure by Application

13.4 South America Contraceptive Drugs and Devices Consumption Volume by Major Countries

13.4.1 Brazil Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

13.4.2 Argentina Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

13.4.3 Columbia Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

13.4.4 Chile Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

13.4.5 Venezuela Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

13.4.6 Peru Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

13.4.8 Ecuador Contraceptive Drugs and Devices Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Contraceptive Drugs and Devices Business

14.1 Bayer Healthcare

14.1.1 Bayer Healthcare Company Profile

14.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Specification

14.1.3 Bayer Healthcare Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Merck

14.2.1 Merck Company Profile

14.2.2 Merck Contraceptive Drugs and Devices Product Specification

14.2.3 Merck Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Church & Dwight

14.3.1 Church & Dwight Company Profile

14.3.2 Church & Dwight Contraceptive Drugs and Devices Product Specification

14.3.3 Church & Dwight Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Warmer Chilcott

14.4.1 Warmer Chilcott Company Profile

14.4.2 Warmer Chilcott Contraceptive Drugs and Devices Product Specification

14.4.3 Warmer Chilcott Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Agile Therapeutics

14.5.1 Agile Therapeutics Company Profile

14.5.2 Agile Therapeutics Contraceptive Drugs and Devices Product Specification

14.5.3 Agile Therapeutics Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Pfizer

14.6.1 Pfizer Company Profile

14.6.2 Pfizer Contraceptive Drugs and Devices Product Specification

14.6.3 Pfizer Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 BioSante Pharmaceuticals

14.7.1 BioSante Pharmaceuticals Company Profile

14.7.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Specification

14.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Mayer Laboratories

14.8.1 Mayer Laboratories Company Profile

14.8.2 Mayer Laboratories Contraceptive Drugs and Devices Product Specification

14.8.3 Mayer Laboratories Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Pantarhei Bioscience

14.9.1 Pantarhei Bioscience Company Profile

14.9.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Specification

14.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Teva Pharmaceutical Industries

14.10.1 Teva Pharmaceutical Industries Company Profile

14.10.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Specification

14.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Contraceptive Drugs and Devices Market Forecast (2022-2027)

15.1 Global Contraceptive Drugs and Devices Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Contraceptive Drugs and Devices Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Contraceptive Drugs and Devices Value and Growth Rate Forecast (2022-2027)

15.2 Global Contraceptive Drugs and Devices Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Contraceptive Drugs and Devices Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Contraceptive Drugs and Devices Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Contraceptive Drugs and Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Contraceptive Drugs and Devices Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Contraceptive Drugs and Devices Consumption Forecast by Type (2022-2027)

15.3.2 Global Contraceptive Drugs and Devices Revenue Forecast by Type (2022-2027)

15.3.3 Global Contraceptive Drugs and Devices Price Forecast by Type (2022-2027)

15.4 Global Contraceptive Drugs and Devices Consumption Volume Forecast by Application (2022-2027)

15.5 Contraceptive Drugs and Devices Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology